A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

Last year
AI
Pharma

Fu­ji­film is all in on AD­Cs, to sell ‘trust’ to boost man­u­fac­tur­ing rev­enues

Last year
Manufacturing

Sage nix­es pro­gram for Parkin­son’s dis­ease af­ter Phase 2 fail­ure

Last year
R&D

In­tra-Cel­lu­lar aims to raise $500M; Lil­ly’s Pre­vail cuts three part­nered pro­grams

Last year
News Briefing

Sanofi's trimmed on­col­o­gy plans lead to $3B biobucks dent for IGM

Last year
Deals
R&D

Lil­ly plans for Zep­bound la­bel ex­pan­sion in­to sleep ap­nea in mid-2024 on back of Phase 3 win

Last year
R&D

Canaan adds $100M+ to boost bio­phar­ma in­vest­ing, brings on for­mer Pfiz­er ex­ec

Last year
People
Financing

GSK of­fers glimpse at pos­i­tive Phase 3 an­tibi­ot­ic da­ta for uro­gen­i­tal gon­or­rhea

Last year
R&D

Fu­ji­film may cut 240 work­ers and re­build ear­ly-stage bi­o­log­ics, CGT unit

Last year
People
Manufacturing

Amy­lyx re­veals full da­ta that drove piv­otal fail­ure for ALS drug: #AAN24

Last year
R&D

Ab­b­Vie inks deal for Med­in­cell's long-act­ing in­jectable plat­form worth up to $1.9B

Last year
Deals
Pharma

Sen­ate bill tar­get­ing WuXi won't af­fect fed­er­al spend­ing, CBO says

Last year
FDA+
Law

Re­gen­eron and Genen­tech bat­tle for oph­thal­mol­o­gists’ affin­i­ty in Eylea HD, Vabysmo matchup

Last year
Pharma
Marketing

FDA hits Nat­co with warn­ing let­ter over In­dia fa­cil­i­ty, sus­pends prod­uct ship­ments to US

Last year
Pharma
FDA+

San­doz's Hu­mi­ra biosim­i­lar nabs sig­nif­i­cant mar­ket share thanks to CVS part­ner­ship

Last year
Pharma

J&J’s mul­ti­ple myelo­ma ther­a­pies dri­ve on­col­o­gy busi­ness de­spite slow Carvyk­ti sales

Last year
Pharma

Charles Riv­er promis­es $500M for ini­tia­tive to de­vel­op al­ter­na­tive test­ing meth­ods and re­duce use of an­i­mals

Last year
Pharma

How drug­mak­ers are han­dling new pres­sure to re­cy­cle plas­tic in­jec­tion pens as mil­lions of new pa­tients be­gin us­ing ...

Last year
Pharma
Marketing

In lat­est turn to au­toim­mune ther­a­pies, Cul­li­nan nabs $280M to join lu­pus space

Last year
Financing
R&D

Take­da’s new deal with Kumquat; IL-2 biotech rais­es $55M

Last year
News Briefing

In­tra-Cel­lu­lar on track for an­oth­er Caply­ta la­bel ex­pan­sion af­ter pos­i­tive Ph3 de­pres­sion da­ta

Last year
R&D

Mar­ket­ingRx roundup: Vi­a­tris taps for­mer Mod­er­na ex­ec for com­mer­cial chief; Mer­ck de­buts PAH ef­fort

Last year
Pharma
Marketing

Ma­ter­nal men­tal health start­up Lu­na­Joy rais­es $4.2M 

Last year
Health Tech

Cor­rec­tion: Boehringer In­gel­heim touts 10-year plan as it eyes over­tak­ing Bay­er as Ger­many’s largest phar­ma

Last year
Pharma
First page Previous page 170171172173174175176 Next page Last page
A service from the Financial Times